Share

April 18, 2017; 88 (16 Supplement) April 28, 2017

Pooled Analysis of Phase 3 studies of ADS-5102 (amantadine hydrochloride) extended release capsules for Levodopa-Induced Dyskinesia: A detailed review of UDysRS Results (S56.003)

Rajesh Pahwa, Caroline Tanner, Robert Hauser, Stuart Isaacson, Reed Johnson, Larissa Felt, Mary Jean Stempien
First published April 17, 2017,
Citation
Permissions

Make Comment

See Comments

Downloads
0

Share

Article Information

vol. 88 no. 16 Supplement S56.003
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • First Published April 17, 2017.
Copyright & Usage: 
© 2017

Author Disclosures

    1. Rajesh Pahwa1,
    2. Caroline Tanner2,
    3. Robert Hauser3,
    4. Stuart Isaacson4,
    5. Reed Johnson5,
    6. Larissa Felt5 and
    7. Mary Jean Stempien5
  1. Rajesh Pahwa1,
  2. Caroline Tanner2,
  3. Robert Hauser3,
  4. Stuart Isaacson4,
  5. Reed Johnson5,
  6. Larissa Felt5 and
  7. Mary Jean Stempien5
  1. 1University of Kansas Medical Center Kansas City KS United States
  2. 2PADRECC, San Francisco VAMC San Francisco CA United States
  3. 3Movement Disorders Center Tampa FL United States
  4. 4Parkinson’s Dis & Mov Dis Ctr of Boca Raton Boca Raton FL United States
  5. 5Adamas Phamaceuticals, Inc. Emeryville CA United States

Article usage

Article usage: April 2017 to January 2023

AbstractFullPdfSource
Apr 20173000Highwire
May 20174100Highwire
Jun 20172100Highwire
Jul 20172500Highwire
Aug 20171500Highwire
Sep 20174300Highwire
Oct 20171200Highwire
Nov 20171500Highwire
Dec 20171700Highwire
Jan 2018900Highwire
Feb 2018400Highwire
Mar 2018600Highwire
Apr 2018100Highwire
May 2018200Highwire
Jun 2018300Highwire
Aug 2018200Highwire
Sep 2018800Highwire
Oct 2018500Highwire
Nov 2018200Highwire
Dec 2018100Highwire
Feb 2019100Highwire
Mar 2019500Highwire
Apr 2019400Highwire
May 2019200Highwire
Jun 2019100Highwire
Jul 2019100Highwire
Aug 2019400Highwire
Sep 2019300Highwire
Nov 2019200Highwire
Dec 2019300Highwire
Mar 2020100Highwire
Apr 2020400Highwire
May 2020300Highwire
Jun 2020300Highwire
Jul 2020500Highwire
Aug 2020400Highwire
Sep 2020100Highwire
Oct 2020300Highwire
Nov 2020300Highwire
Dec 2020100Highwire
Jan 2021100Highwire
Feb 2021100Highwire
Mar 2021300Highwire
Apr 2021200Highwire
May 2021200Highwire
Jun 2021100Highwire
Jul 2021400Highwire
Aug 2021100Highwire
Sep 2021100Highwire
Oct 2021200Highwire
Nov 2021300Highwire
Jan 2022300Highwire
Feb 2022100Highwire
Mar 2022400Highwire
Apr 2022400Highwire
May 2022100Highwire
Jul 2022700Highwire
Aug 2022200Highwire
Oct 2022200Highwire
Nov 2022200Highwire
Dec 2022200Highwire
Jan 2023300Highwire

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Related Articles

  • No related articles found.

Alert Me